From: ELF5 drives angiogenesis suppression though stabilizing WDTC1 in renal cell carcinoma
Patient serial number | Age | Gender | Tumor stage | Tumor grade | Histological subtype |
---|---|---|---|---|---|
1 | 76 | Female | IV | 3 | pRCC I |
2 | 67 | Female | III | 2 | KIRC |
3 | 56 | Male | II | 2 | KIRC |
4 | 45 | Male | II | 2 | KIRC |
5 | 33 | Female | I | 1 | pRCC I |
6 | 77 | Male | II | 1 | chRCC |
7 | 71 | Male | IV | 3 | pRCC II |
8 | 54 | Male | II | 3 | KIRC |
9 | 64 | Female | II | 2 | KIRC |
10 | 69 | Male | IV | 3 | KIRC |
11 | 64 | Male | II | 1 | KIRC |
12 | 47 | Male | I | 1 | KIRC |
13 | 48 | Male | II | 3 | chRCC |
14 | 70 | Male | III | 2 | KIRC |
15 | 60 | Male | III | 4 | KIRC |
16 | 56 | Male | IV | 4 | KIRC |
17 | 54 | Female | II | 2 | KIRC |
18 | 63 | Female | IV | 3 | KIRC |
19 | 52 | Male | II | 2 | pRCC II |
20 | 68 | Female | III | 3 | KIRC |
21 | 62 | Female | III | 3 | chRCC |